• Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

    Recruiting

    2 1 1 1
    Investigated drugs:
    France The Netherlands Poland Spain Sweden
  • Study on the Safety and Effectiveness of AZD0305 Alone and with Other Cancer Drugs for Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Germany Spain
  • Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

    Recruiting

    4 1 1
    Investigated diseases:
    Italy
  • Study Comparing Effects of Ointments with Clotrimazole and Betamethasone Dipropionate for Patients with Moderate to Severe Skin Yeast Infections

    Recruiting

    3 1 1
    Investigated diseases:
    Germany
  • Study on the Effects of Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin for Patients with Squamous Cell Carcinoma of the Penis and Lymph Node Metastasis

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria France Germany Italy Spain
  • Study on the Safety and Effects of CC-92480 with Dexamethasone and Drug Combinations for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Norway Spain
  • Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

    Recruiting

    3 1 1 1
    Investigated diseases:
    Norway
  • Study on Durvalumab, Cisplatin, and Gemcitabine for Patients with Extrahepatic Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study of Larotrectinib and Drug Combination for Children with Newly Diagnosed High-Grade Glioma with NTRK Fusion

    Recruiting

    2 1 1 1
    Investigated diseases:
    Germany

powered by